Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 213   

Articles published

PFE 33.62 0.00 (0.00%)
price chart
Pfizer: Another Reason To Stay Long
There were already plenty of reasons like Pfizer (NYSE:PFE) as a long-term investment but management just gave investors another reason to add to that list when it was recently announced that the company entered into a $5b accelerated share repurchase ...
Pfizer Inc.: Invest For Attractive Valuation And The 4% Dividend Yield
Pfizer Inc. (NYSE:PFE) is one of the world's largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.
EOD Risers: Merck & Co., Inc., Microsoft Corporation, Pfizer Inc., Procter ...
Shares of Merck & Co., Inc. with EPIC code: (NYSE:MRK) a global healthcare company, increased 0.97% or 0.62 points during the course of yesterday's session.
Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today top-line results from ORAL Strategy, a Phase 3B/4 study of XELJANZ� (tofacitinib citrate) 5mg twice daily (BID) in the treatment of moderate to severe rheumatoid arthritis (RA). ORAL ...
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination ...  MarketWatch
Pfizer May Be Another IBM
The stock trades near 30X earnings as if it were about to rebound with great growth. Yet, instead it just may be a lumbering giant making weak decisions not designed to provide rapid organic growth.
What Lies in Store for Pfizer (PFE) this Earnings Season?
Pfizer Inc. PFE will be reporting fourth-quarter and full-year 2016 earnings results on Jan 31, before market open. Last quarter, the company delivered a negative earnings surprise of 1.61%.
Pfizer Inc. (PFE) Closes 0.99% Down on the Day for January 24  Equities.com
Smart Money Buying the Price Weakness of Pfizer, Inc. (NYSE:PFE)  Highland Mirror
Could Pfizer now be a better pick for investors than Johnson & Johnson?
Probably the best investing argument for Pfizer is that it appears to be effectively using its capital to position the company for long-term growth. It's no secret that Pfizer's legacy established products business is struggling, primarily because of ...
Earnings Preview: What To Expect From Pfizer
Pfizer Inc ($PFE) is scheduled to release earnings before Tuesday's open. The pharmaceutical giant hit a record high of $49.99 in 1999 and is currently trading near $31/share.
Form 8-K PFIZER INC For: Feb 02
On February 2, 2017, Pfizer Inc. ("Pfizer") entered into an accelerated share repurchase agreement with Citibank N.A.
Pfizer Said to Hire JPMorgan to Weigh $2 Billion Portfolio Sale  Bloomberg
Here's Why Pfizer Inc. is Still a Great Pick for Income Investors  Income Investors
Earnings Reaction History: Pfizer Inc, 45.5% Follow-Through Indicator, 1.3 ...
Pfizer Inc ( PFE ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement.